Republican healthcare bills in the House and Senate have people concerned about whether they’ll be left uninsured — or underinsured.
Robert Newton has been taking insulin for years to keep his diabetes in check, but with the medication now costing him $500 a month, there are times when he has no choice but to ration his supply and take less than he should.
I applaud the push to rein in insulin prices. In Nevada, we are way ahead of Washington when it comes to sending a message to Big Pharma that enough is enough.
David Hernandez, a 44-year-old restaurant worker and Type 1 diabetic, didn’t have insurance from 2011 through 2014 and often couldn’t afford insulin—a workhorse drug whose list price has risen more than 270 percent over the past decade.
Egyptian medical texts dated around 550 B.C. contain the earliest known descriptions of diabetes.
While Washington wrangles with a replacement for Obamacare, patients across the country continue to battle one of the biggest everyday obstacles to good health care: Rising drug prices.
At age 15, I suddenly felt an unquenchable thirst and began urinating frequently.
Two lawmakers from opposite sides of the aisle have teamed up to ask three powerful health care industries to explain the rising cost of insulin, an essential treatment for people with diabetes.
Millions of consumers are battling rising drug prices.
The number of Americans with diabetes continues to grow, along with the need for insulin therapy.
Gov. Brian Sandoval signed off on a bill Thursday that requires pharmaceutical companies to release insulin prices, weeks after vetoing a similar bill that he said wasn’t strong enough.
Nevada Gov. Brian Sandoval signed into law Thursday the nation’s strictest requirements for pharmaceutical companies to reveal how they set certain prescription drug prices.